The Food and Drug Administration (FDA) approved a generic version of the abortion pill mifepristone in October, making chemical abortion more affordable and accessible to pregnant women who wish to ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...

Abstract: Mobile Crowdsensing (MCS) has become a popular sensing paradigm, where a number of participants use their mobile devices to collectively share and extract information related to a certain ...

The Food and Drug Administration approved a new generic version of a pill used to terminate pregnancies, a decision that comes as the Department of Health and Human Services reviews the drug’s safety.

The Trump administration's approval of generic abortion pills has prompted an immediate and strong condemnation from conservative lawmakers who question the safety of the pill, given the timeline of ...

WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...

The Food and Drug Administration on Tuesday quietly approved a generic form of mifepristone, one of the two medications used in most U.S. abortions. That makes the drug, from the company Evita ...

Oct 2 (Reuters) - The U.S. Food and Drug Administration has approved Evita Solution's generic version of the abortion drug, mifepristone, the regulator said. The FDA said in a letter dated September ...

A generic formulation of Zeposia (ozanimod), which won tentative approval for treating multiple sclerosis (MS) from the U.S. Food and Drug Administration (FDA), will be manufactured and supplied by ...

AbbVie has struck a deal with generic drugmakers aimed at extending patent protection for its blockbuster autoimmune drug Rinvoq well into the next decade. AbbVie on Thursday said it has settled ...

The Trump administration has excluded generic drugs from a baseline 15% tariff on imports from Japan under a new trade deal between the two countries. The “reciprocal” tariffs on Japanese products are ...